Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 29, 2075-2078, November 1, 1969]
© 1969 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kawabe, S.
Right arrow Articles by Sugimura, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kawabe, S.
Right arrow Articles by Sugimura, T.

Crystallization and Properties of Aldolase from a Transplantable Rat Sarcoma1

Sumie Kawabe, Taijiro Matsushima and Takashi Sugimura

Biochemistry Division, National Cancer Center Research Institute, Chuo-ko, Tokyo, Japan

Aldolase was isolated in a crystalline form in a 6% yield from rat Rhodamine sarcomas. The purification involved extraction with Tris-buffer, batchwise treatment with diethylaminoethyl-cellulose, ammonium sulfate fractionation, column chromatography on cellulose phosphate, and crystallization from ammonium sulfate solution (0.35 saturation). The crystalline aldolase preparation behaved as a homogeneous protein during electrophoresis and ultracentrifugal sedimentation. Aldolase of Rhodamine sarcoma was identical to aldolase A of normal rat muscle according to the following criteria: the crystalline aldolase had a specific activity of 12.5 units/mg protein; Km values were 4 x 10-5 M for fructose 1,6-diphosphate and 1 x 10-2 M for fructose 1-phosphate; the activity for fructose 1,6-diphosphate was depressed to 6% of the original by carboxypeptidase A and inhibited completely by anti-aldolase A antibody but not at all by anti-aldolase B antibody; the fructose 1,6-diphosphate activity was inhibited by adenine nucleotides, most etficiently by adenosine triphosphate and less by adenosine diphosphate and adenosine monophosphate.

1 This work was partly supported by Grants No. 9179 from the Ministry of Education and No. 4 from the Ministry of Health of Japan

Received 1/21/69. Accepted 3/18/69.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1969 by the American Association for Cancer Research.